Showing results (61-70 of 688) with videos related to
Sort By:
Pageof 69
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritisFloris van Gaalen, Andreea Ioan-Facsinay, Tom W J Huizinga, et al.Annals of Human Biology|November 1, 1982
Inter-population comparisons of urinary catecholamines: a pilot studyD A Jenner, G A Harrison, J A Day, et al.The Journal of Craniofacial Surgery|February 25, 2000
Effect of human bone morphogenetic protein 2 implant on tooth eruption in an experimental designB Steinberg, D J Chiego, P J Huizinga, et al.Annals of the Rheumatic Diseases|September 29, 2011
Undifferentiated arthritis characteristics and outcomes when applying the 2010 and 1987 criteria for rheumatoid arthritisA Krabben, T W J Huizinga, A H M van der Helm-van MilRheumatology (Oxford, England)|September 29, 2017
Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapySytske Anne Bergstra, Robert B M Landewé, Tom W J Huizinga, et al.Drug Discovery Today|February 6, 2007
Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's diseaseWouter M Kooloos, Dirk J de Jong, Tom W J Huizinga, et al.Current Pharmaceutical Design|August 29, 2014
Biomarkers for radiographic progression in rheumatoid arthritisA Krabben, T W J Huizinga, A H M van der Helm-van MilCurrent Opinion in Rheumatology|March 6, 2016
The role of anticitrullinated protein antibodies in the early stages of rheumatoid arthritisJacqueline Dekkers, René E M Toes, Tom W J Huizinga, et al.Rheumatology (Oxford, England)|March 25, 2017
Dosing down with biologic therapies: a systematic review and clinicians' perspectiveChristopher J Edwards, Bruno Fautrel, Hendrik Schulze-Koops, et al.Current Pharmaceutical Design|March 9, 2010
Pharmacogenetics in treatment of rheumatoid arthritisW M Kooloos, T W J Huizinga, H-J Guchelaar, et al.Pageof 69